Chinese Journal of Tissue Engineering Research ›› 2015, Vol. 19 ›› Issue (50): 8190-8194.doi: 10.3969/j.issn.2095-4344.2015.50.027

Previous Articles     Next Articles

Effect of human placenta-derived mesenchymal stem cells on cytotrophoblast apoptosis in gestational hypertension: study protocol for a randomized controlled trial

Zhang Li1, Li Zhi2, Wang Jing2, Liu Wei2   

  1. 1Shenyang Women’s and Children’s Hospital, Shenyang 110011, Liaoning Province, China; 2Shenyang Central Hospital of Shenyang Medical University, Shenyang 110024, Liaoning Province, China
  • Received:2015-10-12 Online:2015-12-03 Published:2015-12-03
  • Contact: Liu Wei, Shenyang Central Hospital of Shenyang Medical University, Shenyang 110024, Liaoning Province, China
  • About author:Zhang Li, M.D., Associate chief physician, Shenyang Women’s and Children’s Hospital, Shenyang 110011, Liaoning Province, China

Abstract:

BACKGROUND: Excessive apoptosis and decreased infiltration of cytotrophoblasts are essential causes for hypertension in pregnancy. Human placenta-derived mesenchymal stem cells contribute to damage repair, which has been shown in many studies, and moreover, human placenta-derived mesenchymal stem cells have a certain endocrine function and can act on the other tissues in an autocrine or paracrine manner. Therefore, we attempt to explore whether the human placenta-derived mesenchymal stem cell can repair damaged cytotrophoblasts, and then to gestational hypertension.
 
METHODS/DESIGN: This is a randomized controlled cytological experiment. Human placenta-derived mesenchymal stem cell culture medium is collected and filtrated as human placenta-derived mesenchymal stem cell conditioned medium. Human cytotrophoblasts, JEG-3 cells, are cultured and randomized into three groups:15% normal pregnant serum is added in control group; 15% serum from severe pre-eclampsia patients is added in gestational hypertension model group; and in condition medium group, 15% serum from severe pre-eclampsia patients is added for 24 hours of culture, and then human placenta-derived mesenchymal stem cell conditioned medium containing 15% serum from severe pre-eclampsia patients is used instead. Flow cytometry is used to detect cell apoptosis rate.
DISCUSSION: This study will help to find the feasibility of cell transplantation for gestational hypertension by exploring the effect of human placenta-derived mesenchymal stem cells on cytotrophoblasts function in gestational hypertension.
ETHICAL APPROVAL: The protocol is approved by the Ethics Committee of Shenyang Central Hospital of Shenyang Medical University. Informed consent is obtained from normal and pre-eclampsia women in pregnancy. 
 

CLC Number: